AUTHOR=Guo Pan , Tao Fang , Du Lili , Yang Hongmei , Wang Wenguang , Ma Chunpeng , Bi Xile , Ren Lin , Yin Hongtao , Ma Lixiang 

TITLE=Acute kidney injury after myocardial infarction: prognostic implications via dual robust methods

JOURNAL=Frontiers in Medicine

VOLUME=Volume 12 - 2025

YEAR=2025

URL=https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2025.1555478

DOI=10.3389/fmed.2025.1555478

ISSN=2296-858X

ABSTRACT=BackgroundAcute kidney injury (AKI) following acute myocardial infarction (AMI) notably affects patient outcomes. The impact of KDIGO AKI staging on post-discharge short- and long-term outcomes, particularly early-stage AKI, is not well understood. This study evaluates the prognostic implications of various KDIGO stages in AMI patients.MethodsUtilizing the Medical Information Mart for Intensive Care IV (version 3.0) database, this retrospective cohort study included adult patients primarily diagnosed with AMI. Statistical analyses, including doubly robust estimation, propensity score matching, logistic regression, and Cox regression, were performed. The study compared Non-AKI (KDIGO stage 0) with Mild-AKI (maximum KDIGO stage 1 during hospitalization), and Normal-or-mild AKI (KDIGO stages 0–1) with Moderate-to-severe AKI (KDIGO stages 2–3).ResultsAmong 5,715 patients analyzed, 4,306 (75.36%) developed AKI. Doubly robust analysis revealed no significant differences in outcomes between Non-AKI and Mild-AKI groups (28-day mortality: OR 0.97, 95% CI 0.68–1.38; 180-day mortality: HR 0.94, 95% CI 0.76–1.18; 1-year mortality: HR 0.98, 95% CI 0.81–1.20). However, Moderate-to-severe AKI was significantly associated with worse outcomes compared to Normal-or-mild AKI (28-day mortality: OR 1.67, 95% CI 1.36–2.05; 180-day mortality: HR 1.06, 95% CI 1.02–1.10; 1-year mortality: HR 1.22, 95% CI 1.07–1.38; all p < 0.001). Subgroup analyses revealed that patients under 65 years with Mild-AKI showed higher risks of 180-day and 1-year mortality compared to Non-AKI, while Moderate-to-severe AKI consistently demonstrated worse outcomes across all subgroups (age, SOFA score, heart failure status, and renal disease status). These findings were robust across multiple sensitivity analyses.ConclusionsPatients with Mild-AKI can be considered as having “subclinical AKI,” with prognoses similar to Non-AKI patients. In contrast, Moderate-to-severe AKI significantly worsens prognosis compared to Normal-or-mild AKI.